Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trehalose in patients with head trauma
IRCT20121216011763N55Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- May 2025
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3 trial of trehalose in traumatic brain injury (TBI), sponsored by Isfahan University of Medical Sciences. Started May 2025; status: completed.
02
Drugs
trehalose
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on IRCT20121216011763N55.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20121216011763N55.